Elsevier,
Perloff's Clinical Recognition of Congenital Heart Disease (Seventh Edition)
2023, Pages 166-182
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on Ebstein’s anomaly of the tricuspid valve.
Elsevier,
Perloff's Clinical Recognition of Congenital Heart Disease (Seventh Edition)
2023, Pages 283-311
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on fallot tetralogy.
Elsevier,
Perloff's Clinical Recognition of Congenital Heart Disease (Seventh Edition)
2023, Pages 458-471
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insights into truncus arteriosus, a failure of the aorta and pulmonary artery to separate into two distinct structures with their own semilunar valves.
Hepatocellular carcinoma (HCC) accounts for between 85% and 90% of primary liver cancers. It has several interesting epidemiological characteristics.
Development of a siren identification system, using deep learning, for hearing-impaired people. Supports SDG 10.
This Article supports SDGs 3 and 10, assessing the effects of genomics, inheritance, and socioeconomic deprivation on neuropsychiatric risk in children with intellectual disabilities. The study shows that children with genomic variants and intellectual disability are at increased risk of neuropsychiatric difficulties.
How adapting math instruction for those with learning disabilities can allow them to increase their understanding of mathematics. Supports SDGs 4 and 10.
An investigation, linking particularly well to SDGs 10 and 5 focusing on equality, which shows how researchers can actively engage with equality, diversity and inclusion (EDI) in their work, and how EDI considerations must remain an ongoing effort. The authors, working in the field of responsible research and innovation (RRI), intentionally employed EDI in their project recruitment, and reflect here on the adjustments they made as a result. The recruitment of persons with disabilities led to some particularly interesting and new insights in this study looking at trustworthiness in the design of autonomous systems with evolving functionality.
A promising gene therapy called anti-tau ASO shows potential in lowering harmful tau protein linked to Alzheimer's disease.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by outlining key aspects of disability studies and considers how this strongly emerging field is intersecting with scholarship and activism across many varieties of neurodivergence
